Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10.1Revenue $M0.0Net Margin (%)-91,429.4Z-Score-13.7
Enterprise Value $M8.7EPS $-3.1Operating Margin %-74,217.7F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-91,429.4Higher ROA y-yY
Price/Book0.910-y EBITDA Growth Rate %-29.3Quick Ratio0.9Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %5.7Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-79.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-94.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M12.7ROI % (ttm)-120.6Gross Margin Increase y-yN

Gurus Latest Trades with ECTE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ECTE is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ECTE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nordlicht Mark10% Owner 2014-06-30Buy65,739$2.2-66.36 view
Nordlicht Mark10% Owner 2014-06-26Buy17,300$2.2-66.36 view
Nordlicht Mark10% Owner 2014-06-24Buy16,961$2.2-66.36 view
GOLDBERG MICHAEL M 2014-02-28Sell0$0-66.36 view
Nordlicht Mark10% Owner 2013-12-10Buy69,569$2.75-73.09 view
Platinum Partners Value Arbitr10% Owner 2013-07-11Sell0$0-73.09 view
Doman Robert FDirector 2013-03-22Buy15,000$0.8-7.5 view
GRIECO WILLIAMDirector 2013-03-21Buy30,000$0.76-2.63 view
SMITH JAMES FRANCISDirector 2012-08-23Buy20,000$1.47-49.66 view
BURKE KIMBERLY A 2011-10-13Sell0$0-49.66 view

Press Releases about ECTE :

    Quarterly/Annual Reports about ECTE:

    News about ECTE:

    Articles On GuruFocus.com
    5 Healthcare Picks for 2012 Mar 21 2012 

    More From Our Partners
    Echo Therapeutics reports Q3 loss Nov 19 2014 - SEEKINGALPHA

    More From Other Websites
    10-Q/A for Echo Therapeutics, Inc. Nov 22 2014
    10-Q for Echo Therapeutics, Inc. Nov 21 2014
    ECHO THERAPEUTICS, INC. Files SEC form 10-Q/A, Quarterly Report Nov 20 2014
    Echo Therapeutics Announces Third Quarter 2014 Financial Results Nov 19 2014
    Echo Therapeutics Announces Third Quarter 2014 Financial Results Nov 19 2014
    ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Nov 19 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 07 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement Nov 03 2014
    Echo Therapeutics to Present Positive Clinical Trial Results at the 14th Annual Diabetes Technology... Nov 03 2014
    Echo Therapeutics to Present Positive Clinical Trial Results at the 14th Annual Diabetes Technology... Nov 03 2014
    Platinum Comments On Recent Statements Purportedly Made By Echo Therapeutics Oct 06 2014
    Echo Therapeutics Comments On Special Meeting Proxy Contest Threatened By Platinum Management (NY)... Oct 06 2014
    Echo Therapeutics Engages PricewaterhouseCoopers' Restructuring Practice to Explore Financial and... Oct 02 2014
    Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And... Oct 02 2014
    Echo Therapeutics Suspends Operations on Cash Concerns Sep 29 2014
    Platinum Management (NY) LLC Calls for a Special Meeting of Stockholders at Echo Therapeutics, Inc. Sep 29 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Sep 24 2014
    Platinum Management and Newly Elected Board Members Unveil New Financing Plan for Echo Therapeutics Sep 24 2014
    Echo Therapeutics Suspends Operations To Conserve Liquidity Sep 23 2014
    Newly Elected Board Members of Echo Therapeutics to Host Conference Call to Provide Shareholder... Sep 19 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK